All Type of News
Korean ‘Orange Book’ including generic approval information will be created
A database for the Korean-style ‘Orange Book,’ which includes information about approval of generic products, is going to be constructed by this December.
The Ministry of Food and Drug Safety(MFDS) announced a schedu...
Next year’s minimum wages decided at KRW 7,530
As the minimum wages made the highest increase ever for the next year, it is expected to impact businesses in the healthcare industry.
The Minimum Wage Commission held the 11th plenary meeting at the Sejong Governmen...
National Tax Service imposing KRW 15.6 billon additional fine on Daehan New Pharm
Daehan New Pharm announced on the 13th that the Seoul Jungbu Regional National Tax Service charged an addition fee of KRW 15.6 billion, 22.01% of its equity.
The addition fee is followed by consolidated investigation...
‘Coexistence’ of expectations and concerns over appointment of politician as MFDS
As Young-Jin Ryu, Chairman of the Busan Pharmaceutical Association, is appointed as the Jae-In Moon’s first Minister of Food and Drug Safety, employees at the Ministry of Food and Drug Safety(MFDS) seem preoccupied on...
Continuous growth in quasi drug market with high interests in hygiene field
The last year’s quasi drug manufacturing performance was increased by 4.9% to KRW 1.9465 trillion compared to 2015, and the manufacturing performance of products, such as disinfectants and insecticides, due to the inc...
Dong-A Pharm Bacchus’s manufacturing performance of KRW 223.7 billion‘Bacchus,’ a Dong-A Pharm’s energy drink, was known to record a manufacturing performance of KRW 232.7 billion last year.
According to the quasi drug manufacturing performance ...
|
Novartis, “We made payments, but never understood what RTM for”While people are paying interests in whether Novartis shared information internally, it was hard to check clear facts even at examination of a witness from its anticancer depart...
|
Qurient acquires patent of Quinolinyloxyphenylsulfonamides related to cancer treatment
Qurient gave an official notice on the 12th that it acquired a patent of Quinolinyloxyphenylsulfonamides related to cancer treatment.
According to the company, the patent is about the core chemical structure of the a...
Distribution industry pays sharp attention to large private hospitals founding direct distributors
As large private hospitals are about to start direct distribution companies, concerns are amplifying in the pharmaceutical distribution industry.
According to the industry concerned on the 13th, multiple large privat...
MFDS approves ‘Invossa K Inj,’ Korea’s first gene therapy
The Ministry of Food and Drug Safety(MFDS) announced approval of ‘Invossa K Inj,’ a gene therapy for the treatment of osteoarthritis in the knee, on the 12th of July.
Gene therapy is a pharmaceutical product is that ...
